Back

Discussion - PHARM-CHF

26 May 2019 (08:40 - 08:43)
Organised by:
Congress Presentation Part of: Late breaking trial II - Chronic heart failure Chronic Heart Failure HFA Premium Access Heart Failure 2019

12 More presentations in this session

Presentation thumbnail
Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial
Professor M. Schulz (Leipzig, DE)
Slides Video
Presentation thumbnail
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in the Prespecified Subgroup with Heart Failure
Professor P. Rossignol (Monaco, MC)
Slides Video
Presentation thumbnail
Discussion - AMBER.
Video
Presentation thumbnail
Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial
Doctor A. Biolo (Porto Alegre, BR)
Slides Video
Presentation thumbnail
Discussion - Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial
Video

Access the full session

Session thumbnail
Late breaking trial II - Chronic heart failure

The Event

Event poster

Heart Failure 2019

26 May 2019 08:40 CET
You may be interested in
thumbnail
Congress Session
Treatment of cardiovascular comorbidities in patients with heart failure
17 May 2025
thumbnail
Congress Presentation
Evaluation of PHARM-HF, a pharmacist-led heart failure medication titration clinic
27 August 2023
thumbnail
Congress Session
Nursing and Allied Professions Investigator Award
19 May 2025
thumbnail
Webinar
What's new in the diagnosis and treatment of pulmonary hypertension, Part 2. Understanding specific aspects of congenital heart disease, chronic thromboembolic PH, and the patient's voice
20 December 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources